Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Circulation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.79.1.101PMID 2491971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Daytime Fluctuations in Blood of Tissue-Type Plasminogen Activator (t-PA) and Its Fast-Acting Inhibitor (PAI-1)

  1988cited by this paper
• Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.

  1987cited by this paper
• Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation.

  1987cited by this paper
• Circadian variation in the frequency of sudden cardiac death.

  1987cited by this paper
• Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.

  1987cited by this paper
• Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.

  1987cited by this paper
• Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarction.

  1987cited by this paper
• Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis.

  1987cited by this paper
• Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo.

  1986cited by this paper
• Method for the determination of fast acting plasminogen activator inhibitor capacity (PAI-cap) in plasma, platelets and endothelial cells.

  1986cited by this paper
• Increase in Plasma Concentrationof Plasminogen Activator Inhibitor, Fibrinogen, von Willebrand Factor, Factor VIII: Cand in Erythrocyte Sedimentation Rate with Age

  1986cited by this paper
• Time sequence of anginal pain

  1986cited by this paper
• Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay.

  1986cited by this paper
• Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

  1985cited by this paper
• Plasminogen activator inhibitor in the blood of patients with coronary artery disease.

  1985cited by this paper
• Circadian variation in the frequency of onset of acute myocardial infarction.

  1985cited by this paper
• Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.

  1984cited by this paper
• Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma

  1984cited by this paper
• Defective fibrinolysis in survivors of myocardial infarction.

  1984cited by this paper
• Physiologic and Pharmacologic Enhancement of Fibrinolysis

  1984cited by this paper
• Diurnal Distribution of ST‐segment Elevation and Related Arrhythmias in Patients with Variant Angina: A Study by Ambulatory ECG Monitoring

  1983cited by this paper
• An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic Disease

  1983cited by this paper
• A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma

  1982cited by this paper
• Daily modifications of plasma fibrinogen platelets aggregation, Howell's time, PTT, TT, and antithrombin II in normal subjects and in patients with vascular disease.

  1982cited by this paper
• Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.

  1979cited by this paper
• Circadian variation of blood-pressure.

  1978cited by this paper
• Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects.

  1974cited by this paper
• "Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms.

  1972cited by this paper
• Blood Fibrinolytic Activity in Man: Diurnal Variation and the Response to Varying Intensities of Exercise

  1970cited by this paper

• Unlocking the Potential of Circadian Biology for Cardiovascular Health.

  2026cites this paper
• Endothelial Dysfunction and Hemostatic System Activation in Relation to Shift Workers, Social Jetlag, and Chronotype in Female Nurses

  2025cites this paper
• Chronobiological analysis of sex differences in electrocardiographic parameters in spontaneously breathing Wistar rats under tiletamine-zolazepam anaesthesia

  2025cites this paper
• Circadian Rhythms in Ischemic Stroke: From Molecular Pathways to Chronotherapeutic Strategies

  2025cites this paper
• Trials on Timing of Cardiovascular Medication Administration

  2025cites this paper
• Comprehensive Review of Thrombophilia: Pathophysiology, Prevalence, Risk Factors, and Molecular Diagnosis.

  2025cites this paper
• Circadian misalignment disrupts biomarkers of cardiovascular disease risk and promotes a hypercoagulable state

  2024cites this paper
• Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure

  2024cites this paper
• Orchestra of ligand-activated transcription factors in the molecular symphony of SERPINE 1 / PAI-1 gene regulation.

  2024cites this paper
• Clockwork conditioning: Aligning the skeletal muscle clock with time-of-day exercise for cardiometabolic health

  2024cites this paper
• Smoking timing, genetic susceptibility, and the risk of incident atrial fibrillation: a large prospective cohort study

  2024cites this paper
• Inherited Disorders of the Fibrinolytic Pathway: Pathogenic Phenotypes and Diagnostic Considerations of Extremely Rare Disorders

  2024cites this paper
• Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight

  2023cites this paper
• Enhancing circadian rhythms—the circadian MEGA bundle as novel approach to treat critical illness

  2023cites this paper
• Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis.

  2023cites this paper
• “Super” SERPINs—A stabilizing force against fibrinolysis in thromboinflammatory conditions

  2023cites this paper
• Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes

  2023cites this paper
• Development of circadian neurovascular function and its implications

  2023cites this paper
• Association of accelerometer-derived circadian abnormalities and genetic risk with incidence of atrial fibrillation

  2023cites this paper
• Diurnal Oscillations of Fibrinolytic Parameters in Patients with Acute Myocardial Infarction and Their Relation to Platelet Reactivity: Preliminary Insights

  2022cites this paper
• Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease

  2022cites this paper
• Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield

  2022cites this paper
• Serial assessment of thrombogenicity and hemodynamics in patients with type II diabetes in a clinical research unit: Evidence for circadian variations in clot formation

  2022cites this paper
• Circadian rhythm and risk of hemorrhagic transformation after acute ischemic stroke treated with intravenous thrombolysis - a systematic review.

  2022cites this paper
• [The influence of the CYP1A2-163 C>A polymorphism on the hemostatic response to exercise following caffeine supplementation].

  2022cites this paper
• Circadian Rhythms and Acute Coronary Syndrome in the Elderly.

  2022cites this paper
• Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy

  2022cites this paper
• Fibrinolysis and bleeding of unknown cause

  2021cites this paper
• Edoxaban Dosing Time Affects Blood Coagulation Inhibition in Rats

  2021cites this paper
• Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.

  2021cites this paper
• Circadian control of human cardiovascular function.

  2021cites this paper
• Disorders of Fibrinogen and Fibrinolysis.

  2021cites this paper
• COVID-19: Sleep, Circadian Rhythms and Immunity – Repurposing Drugs and Chronotherapeutics for SARS-CoV-2

  2021cites this paper
• Effect of Caffeine on the Hemostatic Response to Firefighting Drills

  2020cites this paper
• Physiology of Haemostasis: Plasmin-Antiplasmin System

  2020cites this paper
• Fibrinolytic Pathway Disorders

  2020cites this paper
• Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions

  2020cites this paper
• Time to exercise: Circadian regulation of cardiac preconditioning

  2020cites this paper
• The Role of Clock Genes in Fibrinolysis Regulation: Circadian Disturbance and Its Effect on Fibrinolytic Activity

  2020cites this paper
• The impact of acute exercise on factor VIII in young e-cigarette smokers

  2020cites this paper
• A novel ELISA for the detection of active form of plasminogen activator inhibitor-1 based on a highly specific trapping agent.

  2019cites this paper
• Preliminary result of randomized trial of an oral thrombolytic agent for deep venous thrombosis, cardiac emboli and carotid atheromatous plaques in patients with infarctive stroke: a report of three (3) cases

  2019cites this paper
• An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1.

  2019cites this paper
• The circadian rhythm of selected parameters of the hemostasis system in healthy people.

  2019cites this paper
• Time of day, but not sleep restriction, affects markers of hemostasis following heavy exercise.

  2019cites this paper
• The Influence of Tissue Plasminogen Activator I/D Polymorphism on the tPA Response to Exercise

  2018cites this paper
• Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis

  2018cites this paper
• Acquired and Genetic Thrombotic Risk Factors in the Athlete

  2018cites this paper
• Hemorrhagic disorders of fibrinolysis: a clinical review

  2018cites this paper
• Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin-induced model of liver injury

  2018cites this paper
• Plasminogen activator inhibitor-1 activity and long-term outcome in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: a prospective cohort study

  2018cites this paper
• Role of the circadian system in cardiovascular disease.

  2018cites this paper
• Diurnal rhythm in clinical chemistry: An underrated source of variation

  2018cites this paper
• Circadian locomotor output cycles kaput accelerates atherosclerotic plaque formation by upregulating plasminogen activator inhibitor-1 expression

  2018cites this paper
• Cronopatología del infarto de miocardio y moduladores cronobiológicos en la efectividad de la estrategia terapéutica

  2017cites this paper
• Coordination of cardiac rhythmic output and circadian metabolic regulation in the heart

  2017cites this paper
• Metabolite and hormone rhythms : the effect of obesity type two diabetes and meal timing.

  2017cites this paper
• Impact of rapid weight reduction on health and performance related indicators of athletes representing the Olympic combat sports

  2017cites this paper
• Sudden death circadian rhythm in Chagasic patients compared to non-Chagasic patients

  2017cites this paper
• Low-moderate urine arsenic and biomarkers of thrombosis and inflammation in the Strong Heart Study

  2017cites this paper
• Platelets and Fibrinolysis

  2017cites this paper
• Circadian Rhythms in Adipose Tissue Physiology.

  2017cites this paper
• Wound Care Teaching Module Using Standardized Assessment Tool

  2017cites this paper
• Intracellular high cholesterol content disorders the clock genes, apoptosis-related genes and fibrinolytic-related genes rhythmic expressions in human plaque-derived vascular smooth muscle cells

  2017cites this paper
• Translational Applications of Circadian Rhythms in Cardiology: Chronotherapy and Chronobiomarkers in Cardiovascular Disease

  2017cites this paper
• Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs.

  2017cites this paper
• Sex Differences in the Impact of Shift Work Schedules on Pathological Outcomes in an Animal Model of Ischemic Stroke.

  2016cites this paper
• Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility.

  2016cites this paper
• Tenecteplase and alteplase in acute ischaemic stroke thrombolysis : clinical and imaging study

  2016cites this paper
• The effect of sleep restriction on coagulation and fibrinolysis after heavy exercise

  2016cites this paper
• Plasmin-Antiplasmin System

  2016cites this paper
• Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjects

  2016cites this paper
• Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

  2016cites this paper
• Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk

  2016cites this paper
• Matrix Metalloproteinase-2 (MMP-2) and Plasminogen Activator Inhibitor-1 (PAI-1) in Peritoneal Dialysis: Biological Implications and Clinical Utility

  2015cites this paper
• Evaluating PAI-1 as a biomarker for stress in diving: human serum total PAI-1 is unaltered after 2 h dry exposures to 280 kPa hyperbaric air

  2015cites this paper
• Brachial artery endothelial function is stable across the morning in young men

  2015cites this paper
• Correlation between P-Selectin Level and Left Atrial Function in Rheumatic Mitral Stenosis

  2015cites this paper
• Therapeutic applications of circadian rhythms for the cardiovascular system

  2015cites this paper
• Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity

  2015cites this paper
• The effects of acute garlic supplementation on the fibrinolytic and vasoreactive response to exercise

  2015cites this paper
• PAI at breakfast (whether you like it or not).

  2014cites this paper
• Fibrinolysis for intermediate-risk pulmonary embolism.

  2014cites this paper
• Fibrinolysis for intermediate-risk pulmonary embolism.

  2014cites this paper
• Variation and prognostic value of serum plasminogen activator inhibitor‐1 before and after chemotherapy in patients with epithelial ovarian cancer

  2014cites this paper
• Fibrinolysis for intermediate-risk pulmonary embolism.

  2014cites this paper
• Fibrinolytic factors in relation to anthropometry and incident type 2 diabetes.

  2014cites this paper
• Fibrinolysis for intermediate-risk pulmonary embolism.

  2014cites this paper
• Shea cycle plasminogen activator inhibitor-1 ( PAI-1 ) independent of the sleep / wake Human circadian system causes a morning peak in prothrombotic

  2014cites this paper
• Fibrinolysis for intermediate-risk pulmonary embolism.

  2014cites this paper
• Circadian rhythm and cardiovascular disorders

  2014cites this paper
• The influence of a CYP1A2 polymorphism on the hemostatic response to caffeine

  2014cites this paper
• THROMBOSIS AND HEMOSTASIS Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 ( PAI-1 ) independent of the sleep / wake cycle

  2014cites this paper
• Age and aerobic training status effects on plasma and skeletal muscle tPA and PAI-1

  2014cites this paper
• Human tissue-type plasminogen activator

  2014cites this paper
• Circadian variability of fibrinolytic markers and endothelial function in patients with obstructive sleep apnea.

  2014cites this paper
• Fibrinolysis for intermediate-risk pulmonary embolism.

  2014cites this paper
• Lower Framingham risk score and the absence of hypertension are associated with the morning peak in the circadian variation of ST-elevation myocardial infarction onset

  2014cites this paper
• Fibrinolysis for intermediate-risk pulmonary embolism.

  2014cites this paper
• Fibrinolysis for intermediate-risk pulmonary embolism.

  2014cites this paper